Alicia Eimon

551 total citations
14 papers, 317 citations indexed

About

Alicia Eimon is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alicia Eimon has authored 14 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 10 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alicia Eimon's work include Systemic Lupus Erythematosus Research (12 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Alicia Eimon is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Alicia Eimon collaborates with scholars based in Argentina, Spain and United States. Alicia Eimon's co-authors include O Hübscher, Bernardo A. Pons‐Estel, Alejandro Balsa, Hugo R. Scherbarth, Joseph Wajdula, Paul J. Healey, Joan T. Merrill, Ingemar F. Petersson, Sergio Paira and Alberto Spindler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Clinical & Experimental Immunology.

In The Last Decade

Alicia Eimon

13 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicia Eimon Argentina 9 186 170 70 51 44 14 317
Shunhua Guo United States 12 138 0.7× 179 1.1× 73 1.0× 68 1.3× 25 0.6× 22 371
M. A. Petri United States 7 328 1.8× 266 1.6× 95 1.4× 57 1.1× 35 0.8× 10 403
Francesca Miranda Italy 11 213 1.1× 140 0.8× 56 0.8× 63 1.2× 20 0.5× 19 323
E Höfler Austria 6 252 1.4× 226 1.3× 75 1.1× 48 0.9× 61 1.4× 10 368
Gro Østli Eilertsen Norway 11 243 1.3× 247 1.5× 68 1.0× 44 0.9× 62 1.4× 22 367
Punchong Hanvivadhanakul Thailand 7 359 1.9× 305 1.8× 79 1.1× 58 1.1× 98 2.2× 11 481
Iwona Brzosko Poland 8 146 0.8× 125 0.7× 25 0.4× 39 0.8× 30 0.7× 28 276
Sara Croca United Kingdom 8 277 1.5× 208 1.2× 100 1.4× 23 0.5× 21 0.5× 13 343
Tal Gazitt Israel 12 221 1.2× 224 1.3× 32 0.5× 98 1.9× 37 0.8× 31 437
TRDJ Radstake Netherlands 10 118 0.6× 97 0.6× 34 0.5× 43 0.8× 52 1.2× 20 268

Countries citing papers authored by Alicia Eimon

Since Specialization
Citations

This map shows the geographic impact of Alicia Eimon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Eimon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Eimon more than expected).

Fields of papers citing papers by Alicia Eimon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Eimon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Eimon. The network helps show where Alicia Eimon may publish in the future.

Co-authorship network of co-authors of Alicia Eimon

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Eimon. A scholar is included among the top collaborators of Alicia Eimon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Eimon. Alicia Eimon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Eimon, Alicia, et al.. (2017). Association between severe disease course and nephritis with Q222R polymorphism in DNAse I gene among lupus patients: An Argentine multicenter study.. SHILAP Revista de lepidopterología. 41(2). 138–44. 2 indexed citations
3.
Cosatti, Micaela, Paula Alba, Judith Sarano, et al.. (2017). Multicenter study to assess presenteeism in systemic lupus erythematosus and its relationship with clinical and sociodemographic features. Lupus. 27(1). 33–39. 11 indexed citations
4.
Wallace, Daniel J., Vibeke Strand, Joan T. Merrill, et al.. (2016). Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial. Annals of the Rheumatic Diseases. 76(3). 534–542. 98 indexed citations
5.
Pisoni, Cecilia, et al.. (2015). Elevated IL-1β levels in anti-Ro/SSA connective tissue diseases patients with prolonged corrected QTc interval.. PubMed. 33(5). 715–20. 27 indexed citations
6.
Pisoni, Cecilia, Micaela Cosatti, Analía Álvarez, et al.. (2014). Estudio multicéntrico de prevalencia de anticuerpos antirribosomal P en lupus eritematoso sistémico de comienzo juvenil comparado con lupus eritematoso sistémico del adulto. Reumatología Clínica. 11(2). 73–77. 6 indexed citations
7.
Pisoni, Cecilia, Micaela Cosatti, Analía Álvarez, et al.. (2014). Multicentric Prevalence Study of Anti-P Ribosomal Autoantibodies in Juvenile Onset Systemic Lupus Erythematosus Compared With Adult Onset Systemic Lupus Erythematosus. Reumatología Clínica (English Edition). 11(2). 73–77. 7 indexed citations
8.
Hauk, Vanesa, Laura Fraccaroli, Esteban Grasso, et al.. (2014). Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis. Clinical & Experimental Immunology. 177(3). 662–670. 37 indexed citations
9.
10.
Álvarez, Analía, et al.. (2012). 4G/5G plasminogen activator inhibitor-1 and −308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis. Clinical and Experimental Medicine. 14(1). 83–89. 6 indexed citations
11.
Orozco, Gisela, Anna-Karin Abelson, Miguel Á. González‐Gay, et al.. (2009). Study of functional variants of the BANK1 gene in rheumatoid arthritis. Arthritis & Rheumatism. 60(2). 372–379. 41 indexed citations
12.
Rueda‐Medina, Blanca, Mitsu Reddy, Miguel Á. González‐Gay, et al.. (2006). Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis & Rheumatism. 54(12). 3815–3819. 44 indexed citations
13.
Hübscher, O, et al.. (1993). [Anticytoplasm antibodies of polymorphonuclear neutrophils in Wegener's granulomatosis, other autoimmune diseases, and in patients undergoing hemodialysis].. PubMed. 53(2). 113–6.
14.
Hübscher, O, Alicia Eimon, Boris Elsner, & Roberto M. Arana. (1984). Fatal post-partum pulmonary vasculitis in systemic lupus erythematosus. Clinical Rheumatology. 3(4). 547–550. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunhua Guo Breakdown of academic impact, for papers by M. A. Petri Breakdown of academic impact, for papers by Francesca Miranda Breakdown of academic impact, for papers by E Höfler Breakdown of academic impact, for papers by Gro Østli Eilertsen Breakdown of academic impact, for papers by Punchong Hanvivadhanakul Breakdown of academic impact, for papers by Iwona Brzosko Breakdown of academic impact, for papers by Sara Croca Breakdown of academic impact, for papers by Tal Gazitt Breakdown of academic impact, for papers by TRDJ Radstake
Rankless by CCL
2026